Results 21 to 30 of about 2,829 (137)
DEPRESSIVE SYMPTOMS IN FIRST EPISODE SCHIZOPHRENIA: A SIX-MONTH FOLLOW-UP STUDY
Psychiatry and Clinical Psychopharmacology, 2021 Objective: In this study we aimed to find the prevalence of depressive symptoms in first-episode schizophrenia, and to determine the relationship between depressive symptoms and positive/negative symptoms of schizophrenia.
Özcan Uzun +3 more
doaj
The Efficacy of Moclobemide in Treatment of Major Depression
Psychiatry and Clinical Psychopharmacology, 2021 The effectiveness and the tolerence of moclobemde -one of the reversible inhibitors of MAO-A were assessed in an open clinical trial on 19 inpatients with major depression according to DSM.III and with a score of 16 or more on Hamilton Rating Scale of ...
Ayhan EĞRİLMEZ +3 more
doaj
High dose trospium chloride induced manic episode: a case report
Psychiatry and Clinical Psychopharmacology, 2021 Mania typically occurs as part of bipolar affective disorder, but it may occur secondary to neurological causes, metabolic conditions, infections, polycythemia and some of drugs. This kind of a situation is named as secondary mania.
Rabia Bilici +4 more
doaj
Naltrexone treatment of self-injurious behavior in autistic patients and two case reports
Psychiatry and Clinical Psychopharmacology, 2021 Opiates lower the excitation of locus coeruleus via decreasing the firing activity of neurons. It is implicated that dysfunction of opiatergic systems might be mostly responsible for causing social withdrawal behaviour.
Gürkan Odabaşoğlu +2 more
doaj
CLOZAPINE IN TREATMENT-RESISTANT SCHIZOPHRENIA: FOLLOWED-UP STUDY FOR THREE YEARS
Psychiatry and Clinical Psychopharmacology, 2021 Object: In this open trial the efficacy and safety of clozapine in treatment-resistant schizophrenic patients were investigated. Method: Treatment-resistant 29 schizophrenic patients were followed-up for three years.
Aytekin Özşahin +4 more
doaj
Clinical Side Effects of Haloperidol
Psychiatry and Clinical Psychopharmacology, 2021 21 Subjects diagnosed as schizophreniform disorder were given placebo for one week, then treated with haloperidol for 4 weeks with the purpose o f investigating the clinical side effects o f haloperidol.
Servet EBRİNÇ +3 more
doaj
Clozapine in the Treatment of Tardive Dyskinesia: Three Case Reports
Psychiatry and Clinical Psychopharmacology, 2021 The causes and the pathogenesis of tardive dyskinesia (TD) are not well understood. There is no consistently successful treatment for TD. Symptoms of TD could be suppressed by clozapine.
Özcan UZUN +3 more
doaj
Skin Research and Technology, Volume 30, Issue 9, September 2024.
Isabella J. Tan +3 more
wiley +1 more source
P300 ABNORMALITY DUE TO CHRONIC ALCOHOL EXPOSURE IN PATIENTS WITH ALCOHOL DEPENDENCE
Psychiatry and Clinical Psychopharmacology, 2021 Objective: Scalp recorded P300, the long latency event-related potential (ERP) occurring in response to stimulus is primarily originated from subcortical structures, has been reported to be an indicator of neuronal structure change.
M. Fatih Karaaslan +5 more
doaj
Psychiatry and Behavioral Sciences, 2012 Objective: The objective of this study was to examine the relationship between the serum BDNF levels in depressive disorder patients and cognitive functions along with cortisol levels.
Gulfizar Sozeri-Varma +5 more
doaj +1 more source